PITTSBURGH, May 17, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. Mylan ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. FENOFIBRATE VIATRIS contains the active ingredient fenofibrate.

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ:IPXL) today confirms that it has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICOR® ...

Alembic Pharmaceuticals on Thursday said it has received final nod from the US health regulator for fenofibrate tablets, which reduces cholesterol and triglycerides in blood. "Alembic Pharmaceuticals ...

Are you taking Fenofibrate? Are you aware of the dangers of combining Fenofibrate with certain foods, herbs, or alcohol? Drug-food-interactions are seldom discussed but can lead to undesirable side ...

The approved ANDA is bioequivalent and therapeutically equivalent to Tricor tablets of AbbVie Aurobindo Pharma has received final approval from the US Food & Drug Administration (US FDA) to ...

Share price of Alembic Pharmaceuticals rose 3.5 percent intraday Wednesday after company received USFDA approval for Fenofibrate tablets. The company's wholly owned step down subsidiary Orit ...

Scolr Pharma Inc. has commenced pilot bioavailability testing in Canada of its immediate release CDT-fenofibrate tablets. Results from the trial are expected in late 2007. Authorized by the ...

Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has launched its Fenofibrate Tablets, 48 mg and 145 mg strengths in the United States.